• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[皮肤病的视网膜疗法]

[Retinotherapy of skin diseases].

作者信息

Saurat J H

出版信息

Presse Med. 1994 Nov 5;23(34):1551-3.

PMID:7824488
Abstract

The discovery of retinoid receptors has contributed greatly to our understanding of the mechanism of action of vitamin A. The organism produces at least two ligands from ingested vitamin A which act as hormones modulating the activity of numerous genes via their nuclear receptor. These ligands are produced locally by target cells from retinol and retinaldehyde. These advances do not respond to the clinicians' interrogation as to why 13cis retinoic acid blocks sebaceous secretion and cures severe acne while other known retinoids are uneffective. Current research would suggest that the expression of nuclear receptors is not altered in skin diseases but that upstream anomalies in the intracrine system (enzymes and binding proteins) could be involved. Clinically, teratogenic risks are a major obstacle to the oral administration of retinoids and the future in skin diseases lies most likely in topical applications.

摘要

类视黄醇受体的发现极大地促进了我们对维生素A作用机制的理解。机体从摄入的维生素A中产生至少两种配体,它们作为激素,通过其核受体调节众多基因的活性。这些配体由靶细胞从视黄醇和视黄醛局部产生。这些进展并未回应临床医生关于为何13 - 顺式维甲酸能阻断皮脂腺分泌并治愈重度痤疮而其他已知类视黄醇却无效的疑问。目前的研究表明,在皮肤病中核受体的表达并未改变,但内分泌系统(酶和结合蛋白)的上游异常可能与之有关。临床上,致畸风险是类视黄醇口服给药的主要障碍,皮肤病治疗的未来很可能在于局部应用。

相似文献

1
[Retinotherapy of skin diseases].[皮肤病的视网膜疗法]
Presse Med. 1994 Nov 5;23(34):1551-3.
2
Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects.维甲酸:从分子结构、作用机制到皮肤科临床应用及不良反应的历程
J Dermatolog Treat. 2017 Dec;28(8):684-696. doi: 10.1080/09546634.2017.1309349. Epub 2017 Apr 2.
3
Retinoids--which dermatological indications will benefit in the near future?维甲酸类药物——哪些皮肤科适应症在不久的将来会从中受益?
Skin Pharmacol Appl Skin Physiol. 2001 Sep-Oct;14(5):303-15. doi: 10.1159/000056361.
4
[Retinoids in dermatology].[皮肤病学中的维甲酸类药物]
Rev Prat. 1992 Jan 1;42(1):69-75.
5
Retinoids and the skin.维甲酸与皮肤。
Nutr Rev. 1994 Sep;52(9):299-310. doi: 10.1111/j.1753-4887.1994.tb01461.x.
6
Current use and future potential role of retinoids in dermatology.维甲酸类药物在皮肤科的当前应用及未来潜在作用
Drugs. 1997 Mar;53(3):358-88. doi: 10.2165/00003495-199753030-00003.
7
Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids.外用维甲酸类药物的角质溶解和抗炎特性机制。
J Drugs Dermatol. 2005 Jan-Feb;4(1):41-7.
8
Retinoid treatment of skin diseases.维甲酸类药物治疗皮肤疾病。
Eur J Dermatol. 2015 Sep-Oct;25(5):384-91. doi: 10.1684/ejd.2015.2544.
9
Retinoids and vitamin D analogues: action on nuclear transcription.
Hosp Med. 1998 Jan;59(1):12-6.
10
Topical retinoids and cutaneous biology.外用维甲酸与皮肤生物学
Clin Exp Dermatol. 1996 Jan;21(1):1-10.